Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

被引：36

作者：

Jones, Eric D. ^{[1
]}

Vandegraaff, Nick ^{[1
]}

Le, Giang ^{[1
]}

Choi, Neil ^{[1
]}

Issa, William ^{[1
]}

Macfarlane, Katherine ^{[1
]}

Thienthong, Neeranat ^{[1
]}

Winfield, Lisa J. ^{[1
]}

Coates, Jonathan A. V. ^{[1
]}

Lu, Long ^{[2
]}

Li, Xinming ^{[2
]}

Feng, Xiao ^{[2
]}

Yu, Changjiang ^{[2
]}

Rhodes, David I. ^{[1
]}

Deadman, John J. ^{[1
]}

机构：

[1] Avexa Ltd, Richmond, Vic 3121, Australia

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期

关键词：

Integrase; Inhibitor; Synthesis; 3-Hydroxy-pyrido[12-a]pyrimidin-4-one;

D O I：

10.1016/j.bmcl.2010.07.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented. Nine variations of the core scaffold are evaluated leading to optimization of the 6:6 core giving compound 48 with an EC50 of 3 nM against wild type HIV infected T-cells. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5913 / 5917

页数：5

共 50 条

[1] Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: Azoles: Effective metal chelators
Le, Giang
Vandegraaff, Nick
Rhodes, David I.
Jones, Eric D.
Coates, Jonathan A. V.
Thienthong, Neeranat
Winfield, Lisa J.
Lu, Long
Li, Xinming
Yu, Changjiang
Feng, Xiao
Deadman, John J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5909 - 5912
[2] Synthesis and biological evaluation of HIV-1 integrase inhibitors.
Gervay-Hague, J
Meadows, DC
Hadd, MJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U179 - U179
[3] Design, synthesis and structure-activity relationship of HIV-1 integrase inhibitors.
Zhao, H
Neamati, N
Mazumder, A
Pommier, Y
Burke, TR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 21 - MEDI
[4] Understanding the integrase inhibitory activity of azido containing HIV-1 integrase inhibitors.
Karki, RG
Nicklaus, MC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U7 - U7
[5] Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
Muraglia, Ester
Kinzel, Olaf
Gardelli, Cristina
Crescenzi, Benedetta
Donghi, Monica
Ferrara, Marco
Nizi, Emanuela
Orvieto, Federica
Pescatore, Giovanna
Laufer, Ralph
Gonzalez-Paz, Odalys
Di Marco, Annalise
Fiore, Fabrizio
Monteagudo, Edith
Fonsi, Massimiliano
Felock, Peter J.
Rowley, Michael
Summa, Vincenzo
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 861 - 874
[6] The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore
Johns, Brian A.
Weatherhead, Jason G.
Allen, Scott H.
Thompson, James B.
Garvey, Edward P.
Foster, Scott A.
Jeffrey, Jerry L.
Miller, Wayne H.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1802 - 1806
[7] Computational studies of a new library of HIV-1 integrase inhibitors.
Ni, HH
Sotriffer, C
McCammon, AJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U427 - U427
[8] Design and discovery of HIV-1 integrase inhibitors
Neamati, N
Sunder, S
Pommier, Y
DRUG DISCOVERY TODAY, 1997, 2 (11) : 487 - 498
[9] The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors
Kinzel, Olaf D.
Monteagudo, Edith
Muraglia, Ester
Orvieto, Federica
Pescatore, Giovanna
del Rosario, Maria
Ferreira, Rico
Rowley, Michael
Summa, Vincenzo
TETRAHEDRON LETTERS, 2007, 48 (37) : 6552 - 6555
[10] CoMFA and CoMSIA Studies on Inhibitors of HIV-1 Integrase - Bicyclic Pyrimidinones
Radhika, V.
Kanth, S. Sree
Vijjulatha, M.
E-JOURNAL OF CHEMISTRY, 2010, 7 : S75 - S84

← 1 2 3 4 5 →